ARGENX SE Files 6-K for Press Release and Investor Presentation

Ticker: ARGX · Form: 6-K · Filed: Feb 29, 2024 · CIK: 1697862

Sentiment: neutral

Topics: regulatory-filing, investor-relations, press-release

TL;DR

**ARGENX SE just dropped a 6-K, signaling a new press release and investor presentation are out.**

AI Summary

ARGENX SE, a foreign private issuer, filed a Form 6-K on February 29, 2024, to report the issuance of a press release and an investor presentation. The company, with Commission File Number 001-38097, is headquartered at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands. This filing indicates ARGENX SE's ongoing compliance with SEC reporting requirements under the Securities Exchange Act of 1934.

Why It Matters

This filing provides transparency into ARGENX SE's recent communications, allowing investors to access the same information provided to the public and during investor presentations.

Risk Assessment

Risk Level: low — This 6-K filing is a routine disclosure of a press release and investor presentation, not indicating any specific new risks.

Key Players & Entities

FAQ

What type of filing did ARGENX SE submit?

ARGENX SE submitted a Form 6-K, which is a 'Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934'.

When was this 6-K filed?

This 6-K was filed on February 29, 2024.

What was the primary purpose of this 6-K filing by ARGENX SE?

The primary purpose was to report that ARGENX SE issued a press release and an investor presentation on February 29, 2024.

What is ARGENX SE's Commission File Number?

ARGENX SE's Commission File Number is 001-38097.

Where are ARGENX SE's principal executive offices located?

ARGENX SE's principal executive offices are located at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands.

Filing Stats: 317 words · 1 min read · ~1 pages · Grade level 11.2 · Accepted 2024-02-29 16:04:20

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ARGENX SE Date: February 29, 2024 By: /s/ Hemamalini (Malini) Moorthy Name: Hemamalini (Malini) Moorthy Title: General Counsel

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing